CD8A and COVID-19: While the immune response in asymptomatic individuals or patients with mild disease is characterized by activation of CD8+ T cells and Th1 cells, a dysregulated hyperinflammatory syndrome characterizes the immune response in patients with severe or critical COVID-19 (Garcia, 2020; Brodin, 2021).